The biology behind B-cell lymphoma 2 as a target in chronic lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 6, p. 321, doi. 10.1177/2040620716671313
- By:
- Publication type:
- Article
Works matching IS 20406207 AND DT 2016 AND VI 7 AND IP 6
Results: 4
1
2
A clinical update on the role of carfilzomib in the treatment of relapsed or refractory multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 6, p. 330, doi. 10.1177/2040620716667275
- By:
- Publication type:
- Article
3
Recent developments in the management of invasive fungal infections in patients with oncohematological diseases.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 6, p. 345, doi. 10.1177/2040620716656381
- By:
- Publication type:
- Article
4
Review of siltuximab in the treatment of multicentric Castleman's disease.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 6, p. 360, doi. 10.1177/2040620716653745
- By:
- Publication type:
- Article